Rachel Grieder, DPM
Primary Podiatric Medicine · Peoria, ILNPI 1598926289
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 10 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Stryker at 37.4% of the total.
Across 10 payments — averaging $22.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$85
- Orthofix Medical, Inc.$45
- Bioventus LLC$26
- Misonix Inc$20
- Organogenesis Inc.$18
- Paratek Pharmaceuticals, Inc.$17
- plus $17 from 1 others
What the payments were for
- Food & beverage$227100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 3 | $85 |
| Orthofix Medical, Inc. | 2 | $45 |
| Bioventus LLC | 1 | $26 |
| Misonix Inc | 1 | $20 |
| Organogenesis Inc. | 1 | $18 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
| Melinta Therapeutics, LLC | 1 | $17 |
How this compares
$227 in reported general payments places this provider in the 55th percentile of 23 primary podiatric medicine providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tavaborole | 18 | $19,834 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 39 | $1,432 |
| Lidocaine | 13 | $1,100 |
| Nitroglycerin PatchNitroglycerin | 13 | $420 |
| Mupirocin | 37 | $323 |
| Doxycycline Monohydrate | 12 | $237 |
| Terbinafine Hcl | 13 | $178 |
| Doxycycline Hyclate | 18 | $173 |
| Cephalexin | 19 | $80 |
| Meloxicam | 22 | $20 |
Paid to pharmacies, not to this prescriber.
Other primary podiatric medicine in Peoria
- John RuffPeoria$2
- John SigleSpringfield$35K
- Jennifer BernsteinLibertyville$10K
- Corey CzarneckiChicago$2K
- Andrew OkeefeChicago$1K
- Matthew KeeneRockford$1K
- Gregory JansynBloomingdale$1K
- Muhammad HussainChicago$592
- Jennifer KaletaNaperville$487
- Raymond HanzelinBerwyn$273
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.